Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Gemma L. Carvill(University of Washington), Sinéad B. Heavin(The University of Melbourne), Simone C. Yendle(The University of Melbourne), Jacinta M. McMahon(The University of Melbourne), Brian J. O’Roak(University of Washington), Joseph Cook(University of Washington), Adiba Khan(University of Washington), Michael O. Dorschner(University of Washington), Molly Weaver(University of Washington), Sophie Calvert(Mater Children's Hospital), Stephen Malone(Mater Children's Hospital), Geoff Wallace(Mater Children's Hospital), Thorsten Stanley(University of Otago), Ann M E Bye(UNSW Sydney), Andrew Bleasel(The University of Sydney), Katherine B. Howell(Royal Children's Hospital), Sara Kivity(Schneider Children's Medical Center), Mark T. Mackay(Royal Children's Hospital), Victoria Rodriguez‐Casero(Monash Medical Centre), Richard Webster(Children's Hospital at Westmead), Amos D. Korczyn(Tel Aviv University), Zaid Afawi(Tel Aviv University), Nathanel Zelnick(Carmel Medical Center), Tally Lerman‐Sagie(Wolfson Medical Center), Dorit Lev(Wolfson Medical Center), Rikke S. Møller, Deepak Gill(Children's Hospital at Westmead), Danielle M. Andrade(University of Toronto), Jeremy L. Freeman(Royal Children's Hospital), Lynette G. Sadleir(University of Otago), Jay Shendure(University of Washington), Samuel F. Berkovic(The University of Melbourne), Ingrid E. Scheffer(Royal Children's Hospital), Heather C. Mefford(University of Washington)
Cited by 693Open Access